SCIWIND BIOSCIENCES
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
SCIWIND BIOSCIENCES
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.sciwind.com.cn
Total Employee:
51+
Status:
Active
Total Funding:
136.34 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Mobile Non Scaleable Content Euro Microsoft Azure DNS DigiCert SSL Pound Sterling Japanese Yen
Similar Organizations
LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.
Rising BioSciences
Rising BioSciences is a research and development company focusing on oral and topical cannabis based pharmaceuticals.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Teligene
Teligene is a drug discovery company edicating to developing innovative small-molecule drugs.
Yidao Biotechnology
Yidao Biotechnology research and develops vaccines and biomedical products.
Current Employees Featured
Martijn Fenaux Senior Vice President @ Sciwind Biosciences
Senior Vice President
2021-08-01
Pan Hai CEO and Chairman @ Sciwind Biosciences
CEO and Chairman
Xinle Wu Chief Scientific Officer @ Sciwind Biosciences
Chief Scientific Officer
Weidong Zhong Chief Strategy Officer & President @ Sciwind Biosciences
Chief Strategy Officer & President
2021-07-01
Founder
Investors List
LYFE Capital
LYFE Capital investment in Series C - Sciwind Biosciences
Zhengxingu Capital
Zhengxingu Capital investment in Series C - Sciwind Biosciences
Loyal Valley Capital
Loyal Valley Capital investment in Series C - Sciwind Biosciences
IDG Capital
IDG Capital investment in Series C - Sciwind Biosciences
Legend Capital
Legend Capital investment in Series B - Sciwind Biosciences
LYFE Capital
LYFE Capital investment in Series B - Sciwind Biosciences
Haibang Capital
Haibang Capital investment in Series B - Sciwind Biosciences
Legend Capital
Legend Capital investment in Series A - Sciwind Biosciences
Shiyu Capital
Shiyu Capital investment in Series A - Sciwind Biosciences
Kawin Technology
Kawin Technology investment in Series A - Sciwind Biosciences
Official Site Inspections
http://www.sciwind.com.cn
- Host name: 121.41.178.166
- IP address: 121.41.178.166
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Sciwind Biosciences"
Sciwind
Sciwind Biosciences . Developing innovative therapies to treat metabolic disease . Our Strategy. We are a fast-growing clinical-stage biopharmaceutical company developing a portfolio of therapeutic candidates for metabolic disease. Our …See details»
Leadership - Sciwind
Prior to founding Sciwind Biosciences, Dr. Pan held leadership roles at Amgen, as well as at China-based Kawin Biotech. Dr. Pan is an accomplished researcher with deep knowledge and …See details»
Sciwind Biosciences - Crunchbase Company Profile & Funding
Www.sciwind.com.cn ; 26,445; Highlights. obfuscated. Total Funding Amount . Unlock for free . Contacts 4. Employee Profiles 4. Investors 8. Similar Companies 15. Recent News & Activity. …See details»
Sciwind Biosciences Co., Ltd. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sciwind Biosciences Co., Ltd. of Hangzhou, Zhejiang. Get the latest business insights from Dun & …See details»
Sciwind Biosciences - LinkedIn
Sciwind Biosciences Biotechnology Research San Ramon, California 368 followers Sciwind Biosciences is a clinical-stage biopharmaceutical company focusing on novel drug discovery for metabolic diseaseSee details»
XW003 T2D NMPA acceptance — Sciwind - sciwindbio.com
About Sciwind Biosciences Sciwind Biosciences is a clinical stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease. Its …See details»
Sciwind Biosciences 2025 Company Profile: Valuation, Funding ...
Sciwind Biosciences General Information Description. Developers of new drugs intended to treat metabolic disorders. The company's drugs contain small molecule, protein and peptide …See details»
Sciwind Company Profile - Office Locations, Competitors ... - Craft
Sciwind has 1 employees across 2 locations and $66.5 m in total funding,. See insights on Sciwind including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Sciwind Headquarters and Office Locations - Craft.co
Sciwind Headquarters and Office Locations. Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit. Button CTA. Sciwind is headquartered in Hangzhou Shi, Ke Ji …See details»
Sciwind Biosciences - VentureRadar
"Xianweida is a science-driven international biomedical company, focusing on the research and development of new biomacromolecule drugs in the fields of liver metabolic diseases and lung …See details»
Hangzhou Sciwind Biosciences Co., Ltd. (杭州先为达生物科技股份 …
了解Hangzhou Sciwind Biosciences Co., Ltd. (杭州先为达生物科技股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的23项临床试验, 21篇新闻，疾病领域:内分泌与代谢疾病，神 …See details»
先为达_杭州先为达生物科技股份有限公司 - sciwind.com.cn
Sep 27, 2022 杭州先为达生物科技有限公司(Sciwind Biosciences)，一家处于临床阶段、专注于研究开发治疗慢性代谢性疾病创新疗法的生物科技公司，今日宣布与施能康(SynerK)，一家专 …See details»
Sino Biopharm, Sciwind Biosciences sign strategic deal
Feb 27, 2025 Sino Biopharmaceutical Limited announced on Thursday that it had signed an exclusive strategic cooperation agreement with Sciwind Biosciences, a biotech company …See details»
Hangzhou Sciwind Biosciences Co., Ltd. - Drug pipelines, Patents ...
Jul 4, 2023 HANGZHOU, China and SAN FRANCISCO, Sept. 5, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering …See details»
Sciwind Biosciences Company Information - Funding, Investors, …
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
先为达_杭州先为达生物科技股份有限公司 - sciwind.com.cn
Jan 10, 2025 欲了解更多信息，请访问：www.sciwind.com.cn。 关于 Verdiva Verdiva是一家处在临床阶段的全球生物制药公司，致力于开发针对肥胖及其并发症，以及其他心血管代谢紊乱 …See details»
Sciwind Biosciences Completes $70 Million Series C Financing and ...
Oct 12, 2021 HANGZHOU, China and SAN FRANCISCO, Oct. 12, 2021 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on …See details»
Sciwind Biosciences and SynerK entered into a research …
SAN FRANCISCO, Calif. and HANGZHOU, China, Sept. 26, 2022 /PRNewswire/ — Sciwind Biosciences, a clinical-stage biopharmaceutical company focused on discovering and …See details»
先为达_杭州先为达生物科技股份有限公司 - sciwind.com.cn
Dec 16, 2024 先为达生物开发了多项包括口服多肽和吸入蛋白给药平台在内的专利技术，并基于核心技术平台确立了一系列候选药物。欲了解更多信息，请访问： www.sciwind.com.cn 。 声 …See details»
先为达生物将在第84届ADA上介绍注射用 ... - vbdata.cn
Jun 22, 2024 Sciwind Biosciences是一家临床阶段的生物制药公司，专注于发现和开发治疗代谢性疾病的创新疗法。 其产品线由潜在的一流和一流的候选药物组成，包括长效GLP-1肽类似 …See details»